291 related articles for article (PubMed ID: 17115578)
21. Dermatologists' level of compliance with the prescription guidelines of isotretinoin for females of childbearing potential.
AlGhamdi KM; Khurram H; Asiri YA; Mandil A
Int J Dermatol; 2011 Sep; 50(9):1094-8. PubMed ID: 22126870
[TBL] [Abstract][Full Text] [Related]
22. The British Association of Dermatologists isotretinoin questionnaire for patients: a useful clinical tool.
McMullen E; Cox NH
Clin Exp Dermatol; 2006 Sep; 31(5):713-4. PubMed ID: 16901319
[No Abstract] [Full Text] [Related]
23. Simplifying contraception requirements for iPLEDGE: A decision analysis.
Barbieri JS; Roe AH; Mostaghimi A
J Am Acad Dermatol; 2020 Jul; 83(1):104-108. PubMed ID: 32068040
[TBL] [Abstract][Full Text] [Related]
24. Isotretinoin systemic therapy and the shadow cast upon dermatology's downtrodden hero.
Lowenstein EB; Lowenstein EJ
Clin Dermatol; 2011; 29(6):652-61. PubMed ID: 22014987
[TBL] [Abstract][Full Text] [Related]
25. A comparative review of the isotretinoin pregnancy risk management programs across four continents.
Kovitwanichkanont T; Driscoll T
Int J Dermatol; 2018 Sep; 57(9):1035-1046. PubMed ID: 29508918
[TBL] [Abstract][Full Text] [Related]
26. Circumventing iPLEDGE: Circumventing ethical responsibility?
Lee KC; Bercovitch L
J Am Acad Dermatol; 2017 Dec; 77(6):1185-1187. PubMed ID: 29132856
[No Abstract] [Full Text] [Related]
27. Terminations of pregnancy associated with isotretinoin use in New Zealand.
Moodie P; Jaine R; Arnold J; Metcalfe S; Bignall M; Arroll B
N Z Med J; 2011 Jul; 124(1339):59-66. PubMed ID: 21952331
[TBL] [Abstract][Full Text] [Related]
28. [Isotretinoin, depression and medias].
Wolkenstein P
Ann Dermatol Venereol; 2010 Nov; 137 Suppl 2():S69-71. PubMed ID: 21095500
[TBL] [Abstract][Full Text] [Related]
29. Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. 2010.
Goodfield MJ; Cox NH; Bowser A; McMillan JC; Millard LG; Simpson NB; Ormerod AD
Br J Dermatol; 2010 Jun; 162(6):1172-9. PubMed ID: 21250961
[No Abstract] [Full Text] [Related]
30. Isotretinoin-induced elkonyxis.
Yung A; Johnson P; Goodfield MJ
Br J Dermatol; 2005 Sep; 153(3):671-2. PubMed ID: 16120167
[No Abstract] [Full Text] [Related]
31. Isotretinoin, Patient Safety, and Patient-Centered Care-Time to Reform iPLEDGE.
Barbieri JS; Frieden IJ; Nagler AR
JAMA Dermatol; 2020 Jan; 156(1):21-22. PubMed ID: 31664426
[No Abstract] [Full Text] [Related]
32. Acute acne flare following isotretinoin administration: potential protective role of low starting dose.
Borghi A; Mantovani L; Minghetti S; Virgili A; Bettoli V
Dermatology; 2009; 218(2):178-80. PubMed ID: 19060474
[No Abstract] [Full Text] [Related]
33. Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program.
Brinker A; Kornegay C; Nourjah P
Arch Dermatol; 2005 May; 141(5):563-9. PubMed ID: 15897377
[TBL] [Abstract][Full Text] [Related]
34. When a uniquely effective drug is teratogenic. The case of isotretinoin.
Stern RS
N Engl J Med; 1989 Apr; 320(15):1007-9. PubMed ID: 2522591
[No Abstract] [Full Text] [Related]
35. Companies warned about unapproved Accutane.
FDA Consum; 2003; 37(6):2. PubMed ID: 14983801
[No Abstract] [Full Text] [Related]
36. Novel management of isotretinoin-induced hypertriglyceridemia in an adolescent with severe acne.
Beach RA; McQueen M; Wismer J
Clin Pediatr (Phila); 2009 Jun; 48(5):551-4. PubMed ID: 19246414
[No Abstract] [Full Text] [Related]
37. What is the best approach to reducing birth defects associated with isotretinoin?
Abroms L; Maibach E; Lyon-Daniel K; Feldman SR
PLoS Med; 2006 Nov; 3(11):e483. PubMed ID: 17121451
[TBL] [Abstract][Full Text] [Related]
38. Differences in acne treatment prescribing patterns of pediatricians and dermatologists: an analysis of nationally representative data.
Yentzer BA; Irby CE; Fleischer AB; Feldman SR
Pediatr Dermatol; 2008; 25(6):635-9. PubMed ID: 19067874
[TBL] [Abstract][Full Text] [Related]
39. Potential subversion of pregnancy prevention program in the managed care setting.
Wilkin JK
Arch Dermatol; 1997 Feb; 133(2):243-4. PubMed ID: 9041846
[No Abstract] [Full Text] [Related]
40. Is oral isotretinoin the treatment of choice in moderate and severe inflammatory acne vulgaris?
Verros CD; Rallis E
J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1270-1. PubMed ID: 17894728
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
